Annual Report
    
News

    
Directory / Bottin
Contact Us
Directions / Maps
Steering Committee
Events & Seminars
MDRC at the forefront
McGarry Lecture
Cahill Lecture
MDRC Core Facilities
Scientific Links
Education & Employment

    
MDRC Grants
Donations
Non-Profit & Industrial Partners
    
JDRF
CDA
Diabetes Quebec
ADA
IDF
NIH / NIDDK
Alfediam
EASD
 Home / About Us > Dr Lawrence Rosenberg > Invited Speaker
Scientific presentation

1. Feldman L, Barkun J, Barkun A, Sampalis J, Rosenberg L. Measuring post-operative complications in general surgery patients using an oitcomes-based strategy: Comparison with complications presented at morbidity and mortality rounds. Central Surgical Association, Chicago, 1997
2. Rosenberg L, MacNeil P, Turcotte L. Economic evaluation of the use of octreotide in prevention of complications following pancreatic resection. Society for the Surgery of the Alimentary Tract. Washington, 1997.
3. Paraskevas S, Maysinger D, Lakey JRT, Cavanagh TJ, Wang R, Rosenberg L. Activation of JNK, p38 and ERK in cultured human, canine and porcine islets. International Pancreas and Islet transplant Association. Milan, 1997.
4. Paraskevas S, Maysinger D, Lakey JRT, Cavanagh TJ, Wang R, Rosenberg L. Modulation of JNK and p38 MAP kinase activity by insulin in human, porcine and canine islets.International Pancreas and Islet transplant Association. Milan, 1997.
5. Paraskevas S, Maysinger D, Lakey JRT, Cavanagh TJ, Rosenberg L. Modulation of JNK and p38 MAP kinase activity by insulin in human, porcine and canine islets. Canadian Diabetes Association, Scientific Meeting. London, 1997.
6. Wang R, Rosenberg L. The natural history of the islet after routine isolation. Canadian Diabetes Association, Scientific Meeting. Calgary, 1998.
7. Rosenberg L, Wang R, Paraskevas S, Maysinger D. Structural and functional changes resulting from islet isolation lead to islet cell death. Society of University Surgeons, New Orleans, 1999.
8. Wang RN, Li JM, Rosenberg L. Factors inducing islet cell transdifferentiation to duct-like epithelial cells. American Pancreatic Association, Chicago, 1999.
9. Paraskevas S, Wang RN, Li J-M, Agapitos D, Maysinger D, Rosenberg L. Insulin-like growth factors promote islet cell survival in vitro through MAP kinase mediated signaling. American Society of Transplant Surgeons, Chicago, 2000.
10. Paraskevas S, Wang RN, Li J-M, Agapitos D, Rosenberg L, Maysinger D. Tacrolimus mediates islet cell survival in vitro: A role for calcineurin inhibition during isolation. American Society of Transplant Surgeons, Chicago, 2000.
11. Rosenberg L, Wang RN, Li J-M, Pittenger G, Duguid WP, Vinik AI. INGAP peptide increases ß-cell mass and insulin content in adult hamsters and reverses STZ diabetes. American Diabetes Association. San Antonio, 2000.
12. Ramaswamy A, Brown RA, Joseph L, Rosenberg L. Outcome of acute pancreatitis: 41 years of management at a university hospital. Society for Surgery of the Alimentary Tract, San Diego, 2000.
13. Fujisato T, Rosenberg L. Development of artificially vascularized tissue scaffolds for islet cell transplantation. Sixth World Biomaterials Congress. Kamuela, Hawaii, 2000.
14. Wang RN and Rosenberg L. Factors mediating the transformation of islets of Langerhans to duct epithelial-like structures. Annual meeting of the CDA/CSEM Profesional Conference, Edmonton, Alberta 2001.
15. Hazrati A and Rosenberg L. The role of TGF-ß in pancreatic islet transdifferentiation. 6th International Congress of Endocrinology, Teheran, Iran, 2001.
16. Petropavlovskaia M, Rosenberg L. Identification and characterization of “small cells” in pancreas. NIH Workshop on Pancreatic Development, Bethesda, 2001.
17. Wissal E-A, Buteau J, Roduit R, Peyot M-L, Hardy S, Joly E, Ghassan D, Rosenberg L, Prentki M. Elevated glucose and saturated fatty acids synergize in causing pancreatic ß-cell death. A.D.A., San Francisco, 2002.
18. Taylor-Fishwick D, Kendall HM, Ray MK, Roy L, Cao Y, Pittenger GL, Rosenberg L, Vinik AI. Induction of INGAP expression through an activation of protein kinase C and cytokine-induced STAT-signaling. A.D.A., San Francisco, 2002.
19. Hazrati A, Jamal A-M, Rosenberg L. The role of transforming growth factor-ß in the transdifferentiation of islets of Langerhans to duct-like epithelial structures. A.D.A., San Francisco, 2002.
20. Jamal A-M, Lipsett M, Hazrati A, Maysinger D, Pittenger GL, Taylor-Fishwick D, Vinik AI, Rosenberg L. INGAP peptide induces in vitro islet cell neogenesis from human duct-like islet progenitor cells. Endocrine Society, San Francisco, 2002.
21. Pittenger GL, Fishwick-Taylor D, Kosuri S, Burcus NL, Rosenberg L, Vinik AI. INGAP peptide- an initiator of neuroendocrine cell (PGP9.5) development and islet transdifferentiation/transcription factor (Pdx-1) expression in normal dog pancreas. Endocrine Society, San Francisco, 2002.
22. Hazrati A, Jamal A-M, Rosenberg L. The role of transforming growth factor-ß in the transdifferentiation of islets of Langerhans to duct-like epithelial structures. Stem Cell Network of Canada, Toronto, 2002.
23. Jamal A-M, Lipsett M, Hazrati A, Rosenberg L. INGAP peptide induces islet cell neogenesis from human pancreatic progenitor. Stem Cell Network of Canada, Toronto, 2002.
24. Lipsett M, Jamal A.M., Rosenberg L. Acinar cell plasticity: An alternate pathway to ß-cell neogenesis. Stem Cell Network of Canada, Toronto, 2002.
25. Petropavlovskaia M, Rosenberg L. Identification and characterization of putative islet cell progenitors. Stem Cell Network of Canada, Toronto, 2002.
26. Tam J, Rosenberg L, and Maysinger D. Islet-neogenesis associated protein enhances neurite outgrowth from DRG neurons. IUPHAR XIVth World Congress of Pharmacology, San Francisco, July 2002.
27. Aikin R, Maysinger D, Rosenberg L. Inhibition of apoptosis in isolated islets of Langerhans leads to increased levels of caspase-dependent cell death. APOPTOSIS 2003, Luxembourg, 2003.
28. Wang G-S, Fieldus WE, Pulido O, Rosenberg L, Scott FW. Neonatal insulitis, nestin expression and diet-modifiable changes in islet homeostasis. ADA, New Orleans, 2003.
29. Lipsett M, Hanley S, Radzioch D, Finegood D, Compton C, Scott F and Rosenberg L. Identification and inhibition of islet cell neogenesis using an anti-INGAP polyclonal antibody. ADA, New Orleans, 2003.
30. Lipsett M, Hanley S, Jamal A-M and Rosenberg L. Development of a novel in vitro model to study acinar-to-islet differentiation. ADA, New Orleans, 2003
31. El-Assaad W, Joly E, Buteau J, Sladek R, Hudson T, Rosenberg L, Prentki M. Novel insights into the biochemical basis of pancreatic ß-cell glucolipotoxicity. ADA, New Orleans, 2003.
32. Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E and Prentki M. Glucagon-Like Peptide-1 Prevents ß-Cell Glucolipotoxicity in Human Islets and INS832/13 Cells. ADA, New Orleans, 2003.
Montreal Diabetes Research Center 2018
Home / About Us   News   Directory / Bottin   Contact Us